Curriculum Vitae
Kohei Yamada
Research assistant professor, Laboratory of Biopharmacy, School of Pharmaceutical Sciences,
University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan
E-mail: k.yamada@u-shizuoka-ken.ac.jp
TEL: +81-54-264-5632
FAX: +81-54-264-5636
1. Birth
June 6, 1995 (27)
2. Education
B.Sc.

Pharmaceutical Sciences

University of Shizuoka

2018(Pharmacokinetic and Pharmacodynamics)
M.Sc.

Pharmaceutical Sciences

University of Shizuoka

2020(Biopharmacy)
3. Job/Research Experience
2020-

JSPS Research fellow (DC1)

2020-

University of Shizuoka(Research assistant professor, School of Pharmaceutical Sciences)

4. Recent research interests
My current research interests include (1) controlling drug absorption at mucosal tissue such as
gastrointestinal tract, respiratory tract, and nasal cavity, (2) establishing in silico modeling andsimulation for drug absorption at mucosal tissue, and (3) oral peptide delivery.
5. Publication list (As of February 21st, 2023)
1. Yamada K., Hayashi Y., Sasaki K., Higuchi K., Shindo T., Shikama H., Sato H., Onoue S.,[Nanocrystal solid dispersion of fuzapladib free acid with improved oral bioavailability] Biopharm.
Drug Dispos., 43(3): 89–97 (2022)
2. Yamada K., Ristroph KD., Kaneko Y., Lu HD., Sato H., Prud’homme RK., Onoue S.,[Clofazimine-Loaded Mucoadhesive Nanoparticles Prepared by Flash Nanoprecipitation for
Strategic Intestinal Delivery] Pharm. Res., 38(12): 2109–2118 (2021)

3. Ghosh A., Banik S., Suzuki Y., Mibe Y., Rikimura S., Komamoto T., Kuromi K., Yamada K., SatoH., Onoue S., [Lysophosphatidylcholine-based liposome to improve oral absorption andnephroprotective effects of astaxanthin] J. Sci. Food Agric., 12329 (2022)
4. Sato H., Yamane C., Higuchi K., Shindo T., Shikama H., Yamada K., Onoue S., [Development ofstabilized fuzapladib solution for injection: forced degradation study and pharmacokineticevaluation.] Pharmaceutical Development and Technology, 27(5): 565–571 (2022)
5. Banik S., Yamada K., Sato H., Onoue S., [Development of Poly(lipoic acid) Nanoparticles withImproved Oral Bioavailability and Hepatoprotective Effects of Quercetin.] Molecular
Pharmaceutics, 19(5): 1468–1476 (2022)
6. Ohtake H., Tokuyoshi Y., Iyama Y., Nukaga T., Nishida H., Ohtake T., Hirota M., Yamada K., SetoY., Sato H., Kouzuki H., Onoue S., [Reactive oxygen species (ROS) assay-based photosafety
screening for complex ingredients: Modification of the ROS assay protocol.] The Journal of
Toxicological Scicences, 47(11): 483–492 (2022)
7. Sato H., Kaneko Y., Yamada K., Ristroph KD., Lu HD., Seto Y., Chan HK., Prud’homme RK.,
Onoue S., [Polymeric Nanocarriers With Mucus-Diffusive and Mucus-Adhesive Properties toControl Pharmacokinetic Behavior of Orally Dosed Cyclosporine A.] J. Pharm. Sci., 109(2): 1079–1085 (2020)
6. Award
1. Best Presentation Award of Tokai-region of the Pharmaceutical Society of Japan (2017)
2. Travel Award of the 2nd Workshop for Japan-Korea Young Scientists on Pharmaceutics (KJYSP,2018)
3. Travel Award of the 3rd Workshop for Japan-Korea Young Scientists on Pharmaceutics (JKPW,2019)
4. JSPS Research Fellow (DC1) (2020)
5. Nagai Foundation Scholarship of the Academy of Pharmaceutical Science and Technology, Japan(APSTJ, 2020)
6. The Award of Japan Autophagy Consortium (2022)